Columbia University, EndoRobotics Ink License On Micro-robotic Imaging Device
Main Category: Medical Devices / DiagnosticsArticle Date: 27 May 2009 - 4:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4 (1 votes) |
Columbia University Science & Technology Ventures (STV) and New York-based EndoRobotics, Inc. have entered into an exclusive license agreement to develop and commercialize a micro-robotic imaging and surgical device platform designed to reduce the complexity of minimally invasive surgical (MIS) procedures and improve patient outcomes.
Advantages of MIS approaches over open surgical procedures include reduced trauma from multiple small incisions compared to one large incision, better preservation of pulmonary function, quicker return of gastrointestinal function, and reduced stress response, leading to better preservation of immune function. Recent reports also document fewer incisional hernias and intestinal obstructions after MIS as compared to traditional open surgeries. However, only about 10% of all lung resections and fewer than 7% of colon resections in the U.S. are performed using laparoscopic techniques because existing technology requires extensive training and significant dexterity to operate.
To address that issue, privately held start-up EndoRobotics is developing a micro-robotic camera designed to reduce the complexity of MIS procedures. Called VisionTrackerOne, the device is controlled by surgeons using intuitive motions. The company is pursuing seven indications for clinical approval that, collectively, represent more than four million open surgical procedures annually.
Source
News Blaze
Visit our medical devices / diagnostics section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/151489.php>
APA
http://www.medicalnewstoday.com/releases/151489.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




